FOXO1 silencing decreases DCT toxicity in PCa cells by counteracting the DCT-dependent increases in nuclear FOXO1 and the resulting FOXO1-dependent cell death induction [23]. The gene discussed is FOXO1; the disease is posterior cortical atrophy.